PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.92%
Revenue growth above 1.5x 3141.T's 0.22%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
5.52%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
29.29%
Positive EBIT growth while 3141.T is negative. John Neff might see a substantial edge in operational management.
35.99%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
30.23%
Positive net income growth while 3141.T is negative. John Neff might see a big relative performance advantage.
30.21%
Positive EPS growth while 3141.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
30.21%
Positive diluted EPS growth while 3141.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.27%
10Y revenue/share CAGR under 50% of 3141.T's 171.21%. Michael Burry would suspect a lasting competitive disadvantage.
-14.00%
Negative 5Y CAGR while 3141.T stands at 58.30%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
37.58%
3Y revenue/share CAGR at 50-75% of 3141.T's 56.88%. Martin Whitman would question if the firm lags behind competitor innovations.
100.00%
10Y OCF/share CAGR in line with 3141.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
204.55%
Net income/share CAGR at 50-75% of 3141.T's 362.24%. Martin Whitman might question if the firm’s product or cost base lags behind.
1.06%
Below 50% of 3141.T's 38.26%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
46.13%
3Y net income/share CAGR 50-75% of 3141.T's 71.10%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
174.00%
Equity/share CAGR of 174.00% while 3141.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
20.89%
Below 50% of 3141.T's 108.94%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
67.68%
3Y equity/share CAGR 1.25-1.5x 3141.T's 47.86%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.00%
Firm’s AR is declining while 3141.T shows 4.88%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
0.71%
Inventory shrinking or stable vs. 3141.T's 14.25%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
0.86%
Asset growth well under 50% of 3141.T's 5.38%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
3.21%
BV/share growth above 1.5x 3141.T's 1.59%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
20.57%
Debt growth far above 3141.T's 15.06%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-0.12%
We cut SG&A while 3141.T invests at 4.34%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.